摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(5-(oxiran-2-yl)furan-2-yl)-1,3-dioxolane

中文名称
——
中文别名
——
英文名称
2-(5-(oxiran-2-yl)furan-2-yl)-1,3-dioxolane
英文别名
2-(5-Oxiranyl-furan-2-yl)-[1,3]dioxolane;2-[5-(oxiran-2-yl)furan-2-yl]-1,3-dioxolane
2-(5-(oxiran-2-yl)furan-2-yl)-1,3-dioxolane化学式
CAS
——
化学式
C9H10O4
mdl
——
分子量
182.176
InChiKey
ZNZFGHAGAMXXNO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.1
  • 重原子数:
    13
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    44.1
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(5-(oxiran-2-yl)furan-2-yl)-1,3-dioxolane乙酸乙酯 为溶剂, 反应 6.5h, 以(5-[1,3]dioxolan-2-yl-furan-2-yl)-acetaldehyde (1.57 g) was obtained as a yellow oil的产率得到(5-[1,3]Dioxolan-2-yl-furan-2-yl)-acetaldehyde
    参考文献:
    名称:
    Antifungal agent containing heterocyclic compound
    摘要:
    本发明提供了一种抗真菌剂,其化学式如下:[其中A1代表3-吡啶基,可以具有取代基,喹啉基,也可以具有取代基等;X1代表由公式—NH—C(═O)—,由公式—C(═O)—NH—等表示的基团;E代表呋喃基,噻吩基,吡咯基,苯基,吡啶基,四唑基,噻唑基或吡唑基;限制条件是A1可以有1到3个取代基,E有一个或两个取代基]。
    公开号:
    US07932272B2
  • 作为产物:
    描述:
    氯碘甲烷5-(1,3-二氧杂戊环-2-基)糠醛 在 lithium chloro-isopropyl-magnesium chloride 、 sodium hydroxide 作用下, 以 四氢呋喃 为溶剂, 以96%的产率得到2-(5-(oxiran-2-yl)furan-2-yl)-1,3-dioxolane
    参考文献:
    名称:
    Organomagnesium Based Flash Chemistry: Continuous Flow Generation and Utilization of Halomethylmagnesium Intermediates
    摘要:
    The generation of highly unstable chloromethylmagnesium chloride in a continuous flow reactor and its reaction with aldehydes and ketones is reported. With this strategy, chlorohydrins and epoxides were synthesized within a total residence time of only 2.6 s. The outcome of the reaction can be tuned by simply using either a basic or an acidic quench. Very good to excellent isolated yields, up to 97%, have been obtained for most cases (30 examples).
    DOI:
    10.1021/acs.orglett.0c02725
点击查看最新优质反应信息

文献信息

  • Novel antifungal agent containing heterocyclic compound
    申请人:Nakamoto Kazutaka
    公开号:US20070105943A1
    公开(公告)日:2007-05-10
    The present invention provides an antifungal agent represented by the formula: [wherein A 1 represents a 3-pyridyl group which may have a substituent, a quinolyl group which may have a substituent, or the like; X 1 represents a group represented by the formula —NH—C(═O)—, a group represented by the formula —C(═O)—NH—, or the like; E represents a furyl group, a thienyl group, a pyrrolyl group, a phenyl group, a pyridyl group, a tetrazolyl group, a thiazolyl group or a pyrazolyl group; with the proviso that A 1 may have 1 to 3 substituents, and E has one or two substituents].
    本发明提供了一种抗真菌剂,其表示为以下式子: [其中A1表示一个3-吡啶基团,可能具有取代基,喹啉基团,可能具有取代基或类似物;X1表示由公式—NH—C(═O)—,由公式—C(═O)—NH—或类似物表示的基团;E表示呋喃基团,噻吩基团,吡咯基团,苯基团,吡啶基团,四唑基团,噻唑基团或吡唑基团;但A1可能具有1到3个取代基,E具有一个或两个取代基。]
  • Novel Antimalarial Agent Containing Heterocyclic Compound
    申请人:Nakamoto Kazutaka
    公开号:US20090227799A1
    公开(公告)日:2009-09-10
    Disclosed is an antimalarial agent containing a compound represented by the formula: [wherein A 1 represents a 3-pyridyl group that may have a substituent, a 6-quinolyl group that may have a substituent, or the like; X 1 represents a group represented by the formula —C(═O)—NH— or the like; E represents a furyl group, a thienyl group or a phenyl group; with the proviso that A 1 may have one to three substituents, and E has one of two substituents] or a salt thereof or hydrates thereof.
    揭示了一种抗疟疾剂,其包含由下式表示的化合物: [其中A1表示一个3-吡啶基团,可以有取代基,一个6-喹啉基团,可以有取代基或类似物;X1表示一个由公式-C(═O)-NH-或类似物表示的基团;E表示一个呋喃基团,噻吩基团或苯基团;但前提是A1可以有1到3个取代基,E有两个取代基之一]或其盐或水合物。
  • Antifungal agent containing heterocyclic compound
    申请人:Eisai R&D Management Co., Ltd.
    公开号:US07932272B2
    公开(公告)日:2011-04-26
    The present invention provides an antifungal agent represented by the formula: [wherein A1 represents a 3-pyridyl group which may have a substituent, a quinolyl group which may have a substituent, or the like; X1 represents a group represented by the formula —NH—C(═O)—, a group represented by the formula —C(═O)—NH—, or the like; E represents a furyl group, a thienyl group, a pyrrolyl group, a phenyl group, a pyridyl group, a tetrazolyl group, a thiazolyl group or a pyrazolyl group; with the proviso that A1 may have 1 to 3 substituents, and E has one or two substituents].
    本发明提供了一种抗真菌剂,其化学式如下:[其中A1代表3-吡啶基,可以具有取代基,喹啉基,也可以具有取代基等;X1代表由公式—NH—C(═O)—,由公式—C(═O)—NH—等表示的基团;E代表呋喃基,噻吩基,吡咯基,苯基,吡啶基,四唑基,噻唑基或吡唑基;限制条件是A1可以有1到3个取代基,E有一个或两个取代基]。
  • NOVEL ANTIFUNGAL AGENT COMPRISING HETEROCYCLIC COMPOUND
    申请人:Eisai Co., Ltd.
    公开号:EP1669348A1
    公开(公告)日:2006-06-14
    The present invention provides an antifungal agent represented by the formula: [wherein A1 represents a 3-pyridyl group which may have a substituent, a quinolyl group which may have a substituent, or the like; X1 represents a group represented by the formula -NH-C(=O)-, a group represented by the formula -C(=O)-NH-, or the like; E represents a furyl group, a thienyl group, a pyrrolyl group, a phenyl group, a pyridyl group, a tetrazolyl group, a thiazolyl group or a pyrazolyl group; with the proviso that A1 may have 1 to 3 substituents, and E has one or two substituents].
    本发明提供了一种由式表示的抗真菌剂: [其中A1代表可具有取代基的3-吡啶基、可具有取代基的喹啉基或类似基团;X1代表由式-NH-C(=O)-代表的基团、由式-C(=O)-NH-代表的基团或类似基团;E 代表呋喃基、噻吩基、吡咯基、苯基、吡啶基、四唑基、噻唑基或吡唑基;但 A1 可具有 1 至 3 个取代基,E 具有 1 或 2 个取代基]。
  • NOVEL ANTIMALARIA AGENT CONTAINING HETEROCYCLIC COMPOUND
    申请人:Eisai R&D Management Co., Ltd.
    公开号:EP1782811A1
    公开(公告)日:2007-05-09
    Disclosed is an antimalarial agent containing a compound represented by the formula: [wherein A1 represents a 3-pyridyl group that may have a substituent, a 6-quinolyl group that may have a substituent, or the like; X1 represents a group represented by the formula -C(=O)-NH- or the like; E represents a furyl group, a thienyl group or a phenyl group; with the proviso that A1 may have one to three substituents, and E has one of two substituents] or a salt thereof or hydrates thereof.
    本发明公开了一种抗疟药剂,其中含有一种由式......表示的化合物: [其中 A1 代表可具有取代基的 3-吡啶基、可具有取代基的 6-喹啉基或类似基团;X1 代表由式-C(=O)-NH-或类似基团表示的基团;E 代表呋喃基、噻吩基或苯基; 但 A1 可具有一至三个取代基,E 具有两个取代基中的一个]或其盐或其水合物。
查看更多

同类化合物

顺式-2-甲基-4-叔-丁基-1,3-二氧戊环 辛醛丙二醇缩醛 碘丙甘油 甜瓜醛丙二醇缩醛 甘油缩甲醛 甘油缩甲醛 环辛基甲醛乙烯缩醛 环戊二烯内过氧化物 环己丙胺,1-(1,3-二噁戊环-2-基)- 环丙羧酸,2-乙酰基-,甲基酯,(1R-顺)-(9CI) 氯乙醛缩乙二醇 柠檬醛乙二醇缩醛 异戊醛丙二醇缩醛 异丁醛-丙二醇缩醛 奥普碘铵 多米奥醇 多效缩醛 壬醛丙二醇缩醛 亲和素 二氰苯乙烯酮乙烯缩醛 乙酮,1-(2-环辛烯-1-基)-,(-)-(9CI) 乙基1,3-二氧戊环-4-羧酸酯 丙炔醛乙二醇缩醛 三甲基-[(2-甲基-1,3-二氧戊环-4-基)甲基]铵碘化物 三丁基(1,3-二恶烷-2-基甲基)溴化鏻 [2-(2-碘乙基)-1,3-二氧戊环-4-基]甲醇 6,8-二氧杂二螺[2.1.4.2]十一烷 6,7-二氧杂双环[3.2.1]辛-2-烯-8-羧酸 5H,8H-呋喃并[3,4:1,5]环戊二烯并[1,2-d]-1,3-二噁唑(9CI) 5-过氧化氢基-5-甲基-1,2-二恶烷-3-酮 5-嘧啶羧酸,4-(2-呋喃基)-1,2,3,4-四氢-6-甲基-2-羰基-,1-甲基乙基酯 5-(哌嗪-1-基)苯并呋喃-2-甲酰胺 5-(1,3-二氧杂烷-2-基)呋喃-2-磺酰氯 5-(1,3-二氧戊环-2-基)戊腈 5,5-二羟基戊醛 4a-乙基-2,4a,5,6,7,7a-六氢-4-(3-羟基苯基)-1-甲基-1H-1-吡喃并英并啶 4-甲基-2-戊基-1,3-二氧戊环 4-甲基-2-十一烷基-1,3-二氧戊环 4-甲基-2-[(1E)-1-戊烯-1-基]-1,3-二氧戊环 4-甲基-2-(三氯甲基)-1,3-二氧戊环 4-甲基-2-(2-(甲硫基)乙基)-1,3-二氧戊环 4-甲基-2-(1-丙烯基)-1,3-二氧戊环 4-甲基-1,3-二氧戊环 4-烯丙基-4-甲基-2-乙烯基-1,3-二氧戊环 4-溴-3,5,5-三甲基二氧戊环-3-醇 4-乙基-1,3-二氧戊环 4-丁基-1,3-二氧戊环 4-[1,3]二氧烷-2-亚甲基丁醛 4-(氯甲基)-2-十七烷基-1,3-二氧戊环 4-(氯甲基)-2-(2-呋喃基)-1,3-二氧戊环